Preclinical pharmacology of amphetamine: Implications for the treatment of neuropsychiatric disorders

LTP and LTD

Malenka, R. C., & Bear, M. F. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.012 · Cited by 3,968 · see citing works

The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway

Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693 · see citing works

The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes

Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529 · see citing works

The debate over dopamine’s role in reward: the case for incentive salience

Berridge, K. C. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0578-x · Cited by 2,347 · see citing works

Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine

Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180 · see citing works

The role of acetylcholine in learning and memory

Hasselmo, M. E. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.09.002 · Cited by 1,693 · see citing works

Role of Endogenous Cannabinoids in Synaptic Signaling

Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,567 · see citing works

Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior

Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.036 · Cited by 1,404 · see citing works

Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders

Autry, A. E., & Monteggia, L. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005108 · Cited by 1,390 · see citing works

NEUROTROPHINS AND SYNAPTIC PLASTICITY

McAllister, A. K., Katz, L. C., & Lo, D. C. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.295 · Cited by 1,337 · see citing works

The NIMH-MATRICS Consensus Statement on Negative Symptoms

Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., & Marder, S. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj053 · Cited by 1,311 · see citing works

Identification of separable cognitive factors in schizophrenia

Nuechterlein, K. H., Barch, D. M., Gold, J. M., Goldberg, T. E., Green, M. F., & Heaton, R. K. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.09.007 · Cited by 1,304 · see citing works

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · see citing works

Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous System

Dani, J. A., & Bertrand, D. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105214 · Cited by 1,197 · see citing works

Towards a glutamate hypothesis of depression

Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036 · see citing works

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

Moghaddam, B., & Javitt, D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.181 · Cited by 1,035 · see citing works

Reward Processing by the Opioid System in the Brain

Le Merrer, J., Becker, J. A. J., Befort, K., & Kieffer, B. L. (2009) · Physiological Reviews · doi:10.1152/physrev.00005.2009 · Cited by 1,013 · see citing works

A meta-analysis of depression severity and cognitive function

McDermott, L. M., & Ebmeier, K. P. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.022 · Cited by 956 · see citing works

Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions

Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948 · see citing works

BDNF and Activity-Dependent Synaptic Modulation: Figure 1.

Lu, B. (2003) · Learning & Memory · doi:10.1101/lm.54603 · Cited by 945 · see citing works

Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies

Ruhé, H. G., Mason, N. S., & Schene, A. H. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001949 · Cited by 861 · see citing works

Dopaminergic Role in Stimulant-Induced Wakefulness

Wisor, J. P., Nishino, S., Sora, I., Uhl, G. R., Mignot, E. J.-M., & Edgar, D. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01787.2001 · Cited by 762 · see citing works

Functional and Anatomical Aspects of Prefrontal Pathology in Schizophrenia

Goldman-Rakic, P. S., & Selemon, L. D. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.3.437 · Cited by 668 · see citing works

Neuromodulation of Brain States

Lee, S., & Dan, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.012 · Cited by 666 · see citing works

Serotoninergic regulation of emotional and behavioural control processes

Cools, R., Roberts, A. C., & Robbins, T. W. (2008) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2007.10.011 · Cited by 656 · see citing works

Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder

Mahan, A. L., & Ressler, K. J. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.06.007 · Cited by 616 · see citing works

What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease

Corti, O., Lesage, S., & Brice, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00022.2010 · Cited by 610 · see citing works

Dopamine: a potential substrate for synaptic plasticity and memory mechanisms

Jay, T. M. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00085-6 · Cited by 576 · see citing works

How Addictive Drugs Disrupt Presynaptic Dopamine Neurotransmission

Sulzer, D. L. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.010 · Cited by 573 · see citing works

5-HT1A receptor function in major depressive disorder

Savitz, J. B., Lucki, I., & Drevets, W. C. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.009 · Cited by 573 · see citing works

Executive functioning in adult ADHD: a meta-analytic review

MARIJE BOONSTRA, A., OOSTERLAAN, J., SERGEANT, J. A., & BUITELAAR, J. K. (2005) · Psychological Medicine · doi:10.1017/s003329170500499x · Cited by 560 · cited 1× · see citing works

Time-Dependent Increases in Brain-Derived Neurotrophic Factor Protein Levels within the Mesolimbic Dopamine System after Withdrawal from Cocaine: Implications for Incubation of Cocaine Craving

Grimm, J. W., Lü, L., Hayashi, T., Hope, B. T., Su, T., & Shaham, Y. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00742.2003 · Cited by 551 · see citing works

Depression and Hippocampal Neurogenesis: A Road to Remission?

Eisch, A. J., & Petrik, D. (2012) · Science · doi:10.1126/science.1222941 · Cited by 516 · see citing works

Practice Parameters for the Treatment of Narcolepsy and other Hypersomnias of Central Origin

Morgenthaler, T. I., Kapur, V. K., Brown, T. M., Swick, T. J., Alessi, C., Aurora, R. N., Boehlecke, B., Chesson, A. L., Friedman, L., Maganti, R., et al. (2007) · Sleep · doi:10.1093/sleep/30.12.1705 · Cited by 488 · see citing works

NMDA Receptor Hypofunction, Parvalbumin-Positive Neurons, and Cortical Gamma Oscillations in Schizophrenia

Gonzalez-Burgos, G., & Lewis, D. A. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs010 · Cited by 478 · see citing works

A neoHebbian framework for episodic memory; role of dopamine-dependent late LTP

Lisman, J., Grace, A. A., & Duzel, E. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.07.006 · Cited by 465 · see citing works

Cognitive impairment in major depression

Marazziti, D., Consoli, G., Picchetti, M., Carlini, M., & Faravelli, L. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.046 · Cited by 448 · see citing works

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436 · see citing works

Potential Adverse Effects of Amphetamine Treatment on Brain and Behavior: A Review

Arcos-Burgos, M., Jain, M., Acosta, M. T., Shively, S., Stanescu, H., Wallis, D., Domené, S., Velez, J. I., Karkera, J., Balog, J. Z., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.90 · Cited by 423 · see citing works

Mechanisms of dopamine transporter regulation in normal and disease states

Vaughan, R. A., & Foster, J. D. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.005 · Cited by 419 · see citing works

The neurobiology and evolution of cannabinoid signalling

Elphick, M. R., & Egertová, M. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2000.0787 · Cited by 416 · see citing works

Psychomotor retardation in depression: Biological underpinnings, measurement, and treatment

Close, J. S., McClintock, S. M., & Croarkin, P. E. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.019 · Cited by 401 · see citing works

The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse

Wee, S., & Koob, G. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1825-8 · Cited by 398 · see citing works

The neurobiology of addiction: a neuroadaptational view relevant for diagnosis

Koob, G. F. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01586.x · Cited by 397 · see citing works

Enhancement of Locomotor Activity and Conditioned Reward to Cocaine by Brain-Derived Neurotrophic Factor

Horger, B. A., Iyasere, C. A., Berhow, M. T., Messer, C. J., Nestler, E. J., & Taylor, J. R. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04110.1999 · Cited by 375 · see citing works

The delta opioid receptor: an evolving target for the treatment of brain disorders

Pradhan, A. A. A., Befort, K., Nozaki, C., Gavériaux‐Ruff, C., & Kieffer, B. L. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.06.008 · Cited by 366 · see citing works

Major Depressive Disorder Treatment Guidelines in America and Europe

Davidson, J. R. T. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.9058se1c.04gry · Cited by 344 · see citing works

Dysregulation of Endogenous Opioid Emotion Regulation Circuitry in Major Depression in Women

Kennedy, S. E., Koeppe, R. A., Young, E. A., & Zubieta, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.11.1199 · Cited by 339 · see citing works

The Role of Hypocretins (Orexins) in Sleep Regulation and Narcolepsy

Taheri, S., Zeitzer, J. M., & Mignot, E. J.-M. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142826 · Cited by 333 · see citing works

Stimulation of Endorphin Neurotransmission in the Nucleus Accumbens by Ethanol, Cocaine, and Amphetamine

Olive, M. F., Koenig, H. N., Nannini, M., & Hodge, C. W. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-j0002.2001 · Cited by 300 · see citing works

Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons

Sun, X., Zhao, Y., & Wolf, M. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4603-04.2005 · Cited by 299 · see citing works

Neurobiological mechanisms for the regulation of mammalian sleep–wake behavior: Reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence

Datta, S., & MacLean, R. R. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.02.004 · Cited by 296 · see citing works

Brain-derived neurotrophic factor rapidly enhances phosphorylation of the postsynaptic N -methyl- d -aspartate receptor subunit 1

Suen, P.-C., Wu, K. M., Levine, E. S., Mount, H. T. J., Xu, J., Lin, S.-Y., & Black, I. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8191 · Cited by 290 · see citing works

Psychomotor stimulants and neuronal plasticity

Wolf, M. E., Sun, X., Mangiavacchi, S., & Chao, S. Z. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.006 · Cited by 288 · see citing works

Improving the Treatment of Schizophrenia: Focus on Serotonin (5-HT)1A Receptors

Millan, M. J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38982-7 · Cited by 287 · see citing works

A Single Infusion of Brain-Derived Neurotrophic Factor into the Ventral Tegmental Area Induces Long-Lasting Potentiation of Cocaine Seeking after Withdrawal

Lü, L., Dempsey, J., Liu, S. Y., Bossert, J. M., & Shaham, Y. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5124-03.2004 · Cited by 282 · see citing works

Functional Selectivity at the μ-Opioid Receptor: Implications for Understanding Opioid Analgesia and Tolerance

Raehal, K. M., Schmid, C. L., Groer, C. E., & Bohn, L. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004598 · Cited by 258 · see citing works

Structural Synaptic Modifications Associated with Hippocampal LTP and Behavioral Learning

Geinisman, Y. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.10.952 · Cited by 256 · see citing works

Understanding the Effects of Stimulant Medications on Cognition in Individuals with Attention-Deficit Hyperactivity Disorder: A Decade of Progress

Swanson, J., Baler, R. D., & Volkow, N. D. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.160 · Cited by 252 · see citing works

AMPA receptor trafficking and the mechanisms underlying synaptic plasticity and cognitive aging

Henley, J. M., & Wilkinson, K. A. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.1/jhenley · Cited by 236 · see citing works

Cataplexy-Active Neurons in the Hypothalamus

John, J., Wu, M., Boehmer, L. N., & Siegel, J. M. (2004) · Neuron · doi:10.1016/s0896-6273(04)00247-8 · Cited by 227 · see citing works

5-HT2A and 5-HT2C/2B Receptor Subtypes Modulate Dopamine Release Induced in Vivo by Amphetamine and Morphine in Both the Rat Nucleus Accumbens and Striatum

Porras, G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00333-5 · Cited by 222 · see citing works

Targeting the Glutamatergic System to Treat Major Depressive Disorder: Rationale and Progress to Date

Mathews, D. C., Henter, I. D., & Zarate, C. A. (2012) · Drugs · doi:10.2165/11633130-000000000-00000 · Cited by 220 · see citing works

Brain serotonergic circuitries

Charnay, Y., & Léger, L. (2010) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2010.12.4/ycharnay · Cited by 211 · see citing works

The cholinergic hypothesis of cognitive aging revisited again: Cholinergic functional compensation

Dumas, J. A., & NEWHOUSE, P. A. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.022 · Cited by 209 · see citing works

A Multicenter, Placebo-Controlled Study of Modafinil Augmentation in Partial Responders to Selective Serotonin Reuptake Inhibitors With Persistent Fatigue and Sleepiness

D, M. F. M., Thase, M. E., & DeBattista, C. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0112 · Cited by 207 · see citing works

A Closer Look at Amphetamine-Induced Reverse Transport and Trafficking of the Dopamine and Norepinephrine Transporters

Robertson, S. D., Matthies, H. J. G., & Galli, A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8053-4 · Cited by 206 · see citing works

Methylphenidate, Dextroamphetamine, and Levamfetamine

Janowsky, D. S. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770030024003 · Cited by 205 · see citing works

Essential Role of Dopamine D 2 Receptor in the Maintenance of Wakefulness, But Not in Homeostatic Regulation of Sleep, in Mice

Qu, W., Xu, X., Yan, M., Wang, Y., Urade, Y., & Huang, Z. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4936-09.2010 · Cited by 199 · see citing works

The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety

Heal, D. J., Cheetham, S. C., & Smith, S. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.020 · Cited by 198 · see citing works

Systematic review of national and international guidelines on attention-deficit hyperactivity disorder

Seixas, M., Weiss, M., & Müller, U. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111412095 · Cited by 197 · see citing works

Dopamine-Regulated MicroRNA MiR-181a Controls GluA2 Surface Expression in Hippocampal Neurons

Saba, R., Störchel, P. H., Aksoy-Aksel, A., Kepura, F., Lippi, G., Plant, T. D., & Schratt, G. M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05896-11 · Cited by 196 · see citing works

The mGlu2 but not the mGlu3 receptor mediates the actions of the mGluR2/3 agonist, LY379268, in mouse models predictive of antipsychotic activity

Woolley, M. L., Pemberton, D. J., Bate, S. T., Corti, C., & Jones, D. N. C. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0974-x · Cited by 189 · see citing works

Neurotrophin-Dependent Modulation of Glutamatergic Synaptic Transmission in the Mammalian CNS

Leßmann, V. (1998) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(98)00190-6 · Cited by 189 · see citing works

Adjunct Modafinil for the Short-Term Treatment of Fatigue and Sleepiness in Patients With Major Depressive Disorder

DeBattista, C., Doghramji, K., Menza, M. A., Rosenthal, M. H., Fieve, R. R., & Modafinil in Depression Study Group (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0911 · Cited by 189 · see citing works

The Psychopathology and Treatment of Bipolar Disorder

Miklowitz, D. J., & Johnson, S. L. (2005) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.2.022305.095332 · Cited by 183 · see citing works

New concepts in prolactin biology

Bernichtein, S., Touraine, P. A., & Goffin, V. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0069 · Cited by 179 · see citing works

Acute and Repeated Systemic Amphetamine Administration: Effects on Extracellular Glutamate, Aspartate, and Serine Levels in Rat Ventral Tegmental Area and Nucleus Accumbens

Xue, C., Ng, J. P., Li, Y., & Wolf, M. E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010352.x · Cited by 177 · see citing works

Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine.

Ritz, M. C., & Kuhar, M. J. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24116-7 · Cited by 176 · see citing works

Amphetamine Paradoxically Augments Exocytotic Dopamine Release and Phasic Dopamine Signals

Daberkow, D. P., Brown, H. D., Bunner, K. D., Kraniotis, S. A., Doellman, M. A., Ragozzino, M. E., Garris, P. A., & Roitman, M. F. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2136-12.2013 · Cited by 165 · see citing works

Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration

Meredith, G. E., Callen, S. E., & Scheuer, D. A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03160-8 · Cited by 158 · see citing works

Interactions between Prolactin and Dopaminergic Neurons1

Moore, K. E. (1987) · Biology of Reproduction · doi:10.1095/biolreprod36.1.47 · Cited by 156 · see citing works

Psychostimulants for depression

Candy, B., Jones, L., Williams, R., Tookman, A., & King, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006722.pub2 · Cited by 156 · see citing works

The chemical nature of the main central excitatory transmitter: A critical appraisal based upon release studies and synaptic vesicle localization

Orrego, F., & Villanueva, S. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90355-j · Cited by 150 · see citing works

5-HT receptors and reward-related behaviour: A review

Hayes, D. J., & Greenshaw, A. J. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.03.005 · Cited by 146 · see citing works

Relevance of Norepinephrine–Dopamine Interactions in the Treatment of Major Depressive Disorder

Mansari, M. E., Guiard, B. P., Chernoloz, O., Ghanbari, R., Katz, N., & Blier, P. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00146.x · Cited by 146 · see citing works

Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review

Westover, A. N., & Halm, E. A. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-41 · Cited by 141 · see citing works

A Randomized, Double-blind, Placebo-controlled Trial of Augmentation With an Extended Release Formulation of Methylphenidate in Outpatients With Treatment-Resistant Depression

Patkar, A. A., Masand, P. S., Pae, C.-U., Peindl, K., Hooper-Wood, C., Mannelli, P., & Ciccone, P. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000246212.03530.fd · Cited by 140 · see citing works

Endogenous Opioid Release in the Human Brain Reward System Induced by Acute Amphetamine Administration

Colasanti, A., Searle, G. E., Long, C. J., Hill, S. P., Reiley, R. R., Quelch, D. R., Erritzøe, D., Tziortzi, A. C., Reed, L. J., Lingford-Hughes, A. R., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.027 · Cited by 140 · see citing works

ADD/ADHD and impaired executive function in clinical practice

Brown, T. E. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0065-7 · Cited by 137 · see citing works

Endocannabinoid tone versus constitutive activity of cannabinoid receptors

Howlett, A. C., Reggio, P. H., Childers, S. R., Hampson, R. E., Ulloa, N. M., & Deutsch, D. G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01364.x · Cited by 126 · see citing works

Balance between Dopamine and Serotonin Release Modulates Behavioral Effects of Amphetamine‐Type Drugs

Rothman, R. B., & Baumann, M. H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.064 · Cited by 123 · see citing works

In vivo monoamine oxidase inhibition by d-amphetamine

Miller, H. H., Shore, P. A., & Clarke, D. E. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90429-3 · Cited by 120 · see citing works

Dopaminergic regulation of cortical acetylcholine release

Day, J. C., & Fibiger, H. C. (1992) · Synapse · doi:10.1002/syn.890120405 · Cited by 120 · see citing works

Osmotic-Release Oral System Methylphenidate Augmentation of Antidepressant Monotherapy in Major Depressive Disorder: Results of a Double-Blind, Randomized, Placebo-Controlled Trial

Ravindran, A. V., Kennedy, S. H., O'Donovan, M. C., Fallu, A., Camacho, F., & Binder, C. E. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0112 · Cited by 119 · cited 1× · see citing works

Stability of surface NMDA receptors controls synaptic and behavioral adaptations to amphetamine

Mao, L., Wang, W., Chu, X., Zhang, G.-C., Liu, X., Yang, Y., Haines, M. M., Papasian, C. J., Fibuch, E. E., Buch, S. J., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2300 · Cited by 113 · see citing works

Brain Dopamine Receptors: A Primer on Their Current Status, Basic and Clinical

Baldessarini, R. J., & Tarazi, F. I. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609017200 · Cited by 112 · see citing works

Amphetamine Increases Phosphorylation of Extracellular Signal-regulated Kinase and Transcription Factors in the Rat Striatum via Group I Metabotropic Glutamate Receptors

Choe, E. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00341-x · Cited by 109 · see citing works

Functional Role of Adult Hippocampal Neurogenesis as a Therapeutic Strategy for Mental Disorders

Jun, H., Hussaini, S. M. Q., Rigby, M. J., & Jang, M. (2012) · Neural Plasticity · doi:10.1155/2012/854285 · Cited by 108 · see citing works

A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: challenges and therapeutic opportunities.

Lindenmayer, J., Nasrallah, H., Pucci, M., James, S., & Citrome, L. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.03.019 · Cited by 108 · see citing works

Naltrexone Attenuates the Subjective Effects of Amphetamine in Patients with Amphetamine Dependence

Jayaram‐Lindström, N., Konstenius, M., Eksborg, S., Beck, O., Hammarberg, A., & Franck, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301572 · Cited by 107 · see citing works

Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths.

Faraone, S. V. (2009) · PubMed Central · Cited by 107 · see citing works

Cognitive enhancers for the treatment of ADHD

Bidwell, L. C., McClernon, F. J., & Kollins, S. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.05.002 · Cited by 101 · see citing works

Protein Kinase Cβ Is a Critical Regulator of Dopamine Transporter Trafficking and Regulates the Behavioral Response to Amphetamine in Mice

Chen, R., Furman, C. A., Zhang, M., Kim, M. N., Gereau, R. W., Leitges, M., & Gnegy, M. E. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.147959 · Cited by 99 · see citing works

Dextro-amphetamine Diminishes Negative Symptoms in Schizophrenia

KAMMEN, D. P. V., & BORONOW, J. J. (1988) · International Clinical Psychopharmacology · doi:10.1097/00004850-198804000-00002 · Cited by 99 · see citing works

Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors

Robinson, J. B. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90201-1 · Cited by 96 · see citing works

On the problem of lamination in the superficial dorsal horn of mammals: A reappraisal of the substantia gelatinosa in postnatal life

Woodbury, C. J., Ritter, A. M., & Koerber, H. R. (2000) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(20000131)417:1 · Cited by 89 · see citing works

The Role of 5-HT3 Receptors in Drug Abuse and as a Target for Pharmacotherapy

Engleman, E., Rodd, Z. A., Bell, R. L., & Murphy, J. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927886 · Cited by 88 · see citing works

Effects of Naltrexone on the Subjective Response to Amphetamine in Healthy Volunteers

Jayaram‐Lindström, N., Wennberg, P., Hurd, Y. L., & Franck, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000144893.29987.e5 · Cited by 88 · see citing works

Recent Advances in Imaging of Dopaminergic Neurons for Evaluation of Neuropsychiatric Disorders

Shen, L., Liao, M.-H., & Tseng, Y.-C. (2012) · BioMed Research International · doi:10.1155/2012/259349 · Cited by 86 · see citing works

Amphetamine-Induced Plasticity of AMPA Receptors in the Ventral Tegmental Area: Effects on Extracellular Levels of Dopamine and Glutamate in Freely Moving Rats

Giorgetti, M., Hotsenpiller, G., Ward, P., Teppen, T. L., & Wolf, M. E. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06362.2001 · Cited by 86 · see citing works

Dopaminergic Regulation of Septohippocampal Cholinergic Neurons

Day, J. C., & Fibiger, H. C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062086.x · Cited by 82 · see citing works

Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania

Valvassori, S. S., Elias, G., de Souza, B., Petronilho, F., Dal-Pizzol, F., Kapczinski, F., Trzesniak, C., Tumas, V., Dursun, S., Nisihara Chagas, M. H., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109106925 · Cited by 80 · see citing works

Nicotinic Mechanisms in the Treatment of Psychotic Disorders: A Focus on the α7 Nicotinic Receptor

D, A. O. M., & Freedman, R. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_8 · Cited by 80 · see citing works

Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus

Impérato, A., Obinu, M. C., & Gessa, G. L. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90869-j · Cited by 80 · see citing works

Cognition in older adults with bipolar disorder versus major depressive disorder

Gildengers, A. G., Butters, M. A., Chisholm, D., Anderson, S., Begley, A. E., Holm, M. B., Rogers, J. C., Reynolds, C. F., & Mulsant, B. H. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.00995.x · Cited by 77 · see citing works

Amphetamine-Induced Place Preference and Conditioned Motor Sensitization Requires Activation of Tyrosine Kinase Receptors in the Hippocampus

Shen, F., Meredith, G. E., & Napier, T. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2898-06.2006 · Cited by 75 · see citing works

Specific Binding of [ ¹¹ C]Raclopride and <i>N</i> -[ ³ H]Propyl-Norapomorphine to Dopamine Receptors in Living Mouse Striatum: Occupancy by Endogenous Dopamine and Guanosine Triphosphate–Free G Protein

Cumming, P., Wong, D. F., Gillings, N., Hilton, J., Scheffel, U., & Gjedde, A. (2002) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1097/00004647-200205000-00011 · Cited by 71 · see citing works

Mediation of Amphetamine-Induced Long-Term Depression of Synaptic Transmission by CB1Cannabinoid Receptors in the Rat Amygdala

Huang, Y.-C., Wang, S., Chiou, L., & Gean, P. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10311.2003 · Cited by 70 · see citing works

Effects of cannabinoids on the anxiety-like response in mice.

Rutkowska, M., Jamontt, J., & Gliniak, H. (2006) · PubMed · Cited by 66 · see citing works

Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation

Carlson, P. J., Merlock, M., & Suppes, T. M. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00132.x · Cited by 63 · see citing works

Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/ Hyperactivity Disorder Who Report Clinically Significant Impairment in Executive Function: Results From a Randomized, Double-Blind, Placebo-Controlled Study

Adler, L. A., Dirks, B., Deas, P. F., Raychaudhuri, A., Dauphin, M. R., Lasser, R. A., & Weisler, R. H. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m08144 · Cited by 62 · cited 1× · see citing works

Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults

Santosh, P. J., Sattar, S., & Canagaratnam, M. (2011) · CNS Drugs · doi:10.2165/11593070-000000000-00000 · Cited by 62 · see citing works

Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration

Lu, W., & Wolf, M. E. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00136-8 · Cited by 61 · see citing works

Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia

Olsson, S. K., Andersson, A., Linderholm, K. R., Holtze, M., Nilsson-Todd, L. K., Schwieler, L., Olsson, E., Larsson, K., Engberg, G., & Erhardt, S. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009383 · Cited by 58 · see citing works

Chronic amphetamine treatment reduces NGF and BDNF in the rat brain

Angelucci, F., Gruber, S. H. M., Khoury, A. E., Tonali, P. A., & Mathé, A. A. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.03.002 · Cited by 57 · see citing works

Amphetamine Induces a Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Reduction in Norepinephrine Transporter Surface Expression Linked to Changes in Syntaxin 1A/Transporter Complexes

Dipace, C., Sung, U., Binda, F., Blakely, R., & Galli, A. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026690 · Cited by 56 · see citing works

Behavioral sensitization to amphetamine is not accompanied by changes in glutamate receptor surface expression in the rat nucleus accumbens

Nelson, C. L., Milovanovic, M., Wetter, J. B., Ford, K. A., & Wolf, M. E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05911.x · Cited by 54 · see citing works

Amphetamine releases dopamine from synaptic vesicles by dual mechanisms

Floor, E., & Meng, L. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)12963-3 · Cited by 54 · see citing works

Coadministration of Modafinil and a Selective Serotonin Reuptake Inhibitor From the Initiation of Treatment of Major Depressive Disorder With Fatigue and Sleepiness: A Double-Blind, Placebo-Controlled Study

Dunlop, B., Crits-Christoph, P., Evans, D., Hirschowitz, J., Solvason, H., Rickels, K., Garlow, S. J., Gallop, R., & Ninan, P. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815abefb · Cited by 52 · see citing works

Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse

Enman, N. M., & Unterwald, E. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.027 · Cited by 51 · see citing works

Amphetamine response and relapse risk after depot neuroleptic discontinuation

ANGRIST, B. M., Peselow, E. D., Rubinstein, M. E., Wolkin, A., & Rotrosen, J. (1985) · Psychopharmacology · doi:10.1007/bf00428187 · Cited by 49 · see citing works

On the mechanism of d‐amphetamine‐induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats

Miele, M., Mura, M. A., Enrico, P., Esposito, G., Serra, P. A., Migheli, R., Zangani, D., MIELE, E., & Desole, M. S. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703066 · Cited by 48 · see citing works

Regulation of the Human Norepinephrine Transporter by Cocaine and Amphetamine

Zhu, M., Shamburger, S., Li, J., & Ordway, G. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38993-1 · Cited by 48 · see citing works

Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain

Karoum, T., Chrapusta, S. J., Brinjak, R., Hitri, A., & Wyatt, R. J. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb17152.x · Cited by 48 · see citing works

The use of serotonergic drugs to treat obesity – is there any hope?

Bello, N. T., & Liang, N.-C. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s11859 · Cited by 47 · see citing works

Amphetamine‐induced locomotion and gene expression are altered in BDNF heterozygous mice

Saylor, A. J., & McGinty, J. F. (2008) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2008.00430.x · Cited by 47 · see citing works

Adjunctive Lisdexamfetamine Dimesylate Therapy in Adult Outpatients With Predominant Negative Symptoms of Schizophrenia: Open-Label and Randomized-Withdrawal Phases

Lasser, R. A., Dirks, B., Nasrallah, H. A., Kirsch, C., Gao, J., Pucci, M. L., Knesevich, M. A., & Lindenmayer, J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.111 · Cited by 46 · see citing works

Pharmacotherapy of Pediatric Attention-Deficit/Hyperactivity Disorder

Vaughan, B., & Kratochvil, C. J. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.005 · Cited by 46 · see citing works

Methylphenidate increases thought disorder in recent onset schizophrenics, but not in normal controls

Levy, D. L., Smith, M. J., Robinson, D. G., Jody, D. N., Lerner, G., Alvir, J. M., Geisler, S., Szymanski, S., Gonzalez, A., Mayerhoff, D. I., et al. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90192-g · Cited by 45 · see citing works

The Pharmacology and Clinical Outcomes of Amphetamines to Treat ADHD

Hodgkins, P., Shaw, M., McCarthy, S., & Sallee, F. R. (2012) · CNS Drugs · doi:10.2165/11599630-000000000-00000 · Cited by 45 · see citing works

Changes in astrocytic basic fibroblast growth factor expression during and after prolonged exposure to escalating doses of amphetamine

Flores, C., & Stewart, J. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00115-9 · Cited by 44 · see citing works

IP3Receptor Sensitization duringIn VivoAmphetamine Experience Enhances NMDA Receptor Plasticity in Dopamine Neurons of the Ventral Tegmental Area

Ahn, K.-C., Bernier, B. E., Harnett, M. T., & Morikawa, H. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4453-09.2010 · Cited by 44 · see citing works

The Nicotinic Acetylcholine Receptor as a Target for Antidepressant Drug Development

Philip, N. S., Carpenter, L. L., Tyrka, A. R., & Price, L. H. (2012) · The Scientific World JOURNAL · doi:10.1100/2012/104105 · Cited by 43 · see citing works

Individual differences in amphetamine sensitization, behavior and central monoamines

Scholl, J. L., Feng, N., Watt, M. J., Renner, K. J., & Forster, G. L. (2008) · Physiology & Behavior · doi:10.1016/j.physbeh.2008.12.001 · Cited by 43 · see citing works

Environmental enrichment increases amphetamine-induced glutamate neurotransmission in the nucleus accumbens: A neurochemical study

Rahman, S., & Bardo, M. T. (2008) · Brain Research · doi:10.1016/j.brainres.2007.12.052 · Cited by 42 · see citing works

Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotion

Pehrson, A. L., & Moghaddam, B. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1914-8 · Cited by 42 · see citing works

Metabolic, toxicological, and safety considerations for drugs used to treat ADHD

Duong, S., Chung, K., & Wigal, S. B. (2012) · Expert Opinion on Drug Metabolism &amp; Toxicology · doi:10.1517/17425255.2012.671295 · Cited by 42 · see citing works

Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test.

Biała, G., Kruk, M., & Budzyńska, B. (2009) · PubMed · Cited by 41 · see citing works

Recent Advances in the Treatment of Narcolepsy

Hirai, N., & Nishino, S. (2011) · Current Treatment Options in Neurology · doi:10.1007/s11940-011-0137-6 · Cited by 38 · see citing works

Amphetamine-Associated Contextual Learning Is Accompanied by Structural and Functional Plasticity in the Basolateral Amygdala

Rademacher, D. J., Rosenkranz, J. A., Morshedi, M. M., Sullivan, E. M., & Meredith, G. E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.6165-09.2010 · Cited by 38 · see citing works

Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT1A receptor knockout mice: Implications for schizophrenia

van den Buuse, M., Ruimschotel, E., Martin, S., Risbrough, V. B., & Halberstadt, A. L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.001 · Cited by 37 · see citing works

Augmented motor activity and reduced striatal preprodynorphin mRNA induction in response to acute amphetamine administration in metabotropic glutamate receptor 1 knockout mice

Mao, L., Conquet, F., & Wang, J. Q. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00284-6 · Cited by 36 · see citing works

Amphetamine-stimulated cortical acetylcholine release: role of the basal forebrain

Arnold, H. M., Fadel, J., Sarter, M. F., & Bruno, J. P. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03328-x · Cited by 36 · see citing works

The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat

Häggkvist, J., Lindholm, S., & Franck, J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.08.021 · Cited by 35 · see citing works

Amphetamine modulation of long‐term potentiation in the prefrontal cortex: dose dependency, monoaminergic contributions, and paradoxical rescue in hyperdopaminergic mutant

Xu, T., Ma, Q., Spealman, R. D., & Yao, W. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07073.x · Cited by 33 · see citing works

Dextroamphetamine treatment of mania.

Garvey, M. J., Hwang, S., Teubner-Rhodes, D., Zander, J., & Rhem, C. (1987) · PubMed · Cited by 33 · see citing works

The effect of lisdexamfetamine dimesylate on body weight, metabolic parameters, and attention deficit hyperactivity disorder symptomatology in adults with bipolar I/II disorder

McIntyre, R. S., Alsuwaidan, M. T., Soczynska, J. K., Szpindel, I., Bilkey, T. S., Almagor, D., Woldeyohannes, H. O., Powell, A. M., Cha, D. S., Gallaugher, L. A., et al. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2325 · Cited by 31 · see citing works

The Dopaminergic Projection System, Basal Forebrain Macrosystems, and Conditioned Stimuli

Zahm, D. S., & Trimble, M. (2008) · CNS Spectrums · doi:10.1017/s1092852900016138 · Cited by 31 · see citing works

D1 and D2 dopamine receptor mediation of amphetamine-induced acetylcholine release in nucleus accumbens

Keys, A. S., & Mark, G. P. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00018-9 · Cited by 31 · see citing works

Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation

Kleijn, J., Wiskerke, J., Cremers, T. I. F. H., Schoffelmeer, A. N. M., Westerink, B. H. C., & Pattij, T. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.03.002 · Cited by 29 · see citing works

Nonstriatal Dopamine D1 Receptors Regulate Striatal Acetylcholine Release In Vivo

Acquas, E., Wilson, C., & Fibiger, H. C. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36622-4 · Cited by 29 · see citing works

Effect of rhynchophylline on central neurotransmitter levels in amphetamine-induced conditioned place preference rat brain

Zhou, J., Mo, Z., & Zhou, S. (2010) · Fitoterapia · doi:10.1016/j.fitote.2010.05.007 · Cited by 28 · see citing works

Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex

Pehek, E. A., & Bi, Y. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00040-7 · Cited by 27 · see citing works

Behavioral response to methylphenidate and treatment outcome in first episode schizophrenia.

Jody, D. N., Lieberman, J. A., Geisler, S., Szymanski, S., & Alvir, J. M. (1990) · PubMed · Cited by 27 · see citing works

Increased synapses in the medial prefrontal cortex are associated with repeated amphetamine administration

Morshedi, M. M., Rademacher, D. J., & Meredith, G. E. (2008) · Synapse · doi:10.1002/syn.20591 · Cited by 26 · see citing works

Early augmentation of sertraline with methylphenidate

Postolache, T. T., Rosenthal, R. N., Hellerstein, D. J., Aromin, R., Kelton, G. M., Muran, J. C., & Londono, J. H. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0210c · Cited by 26 · cited 1× · see citing works

PRECLINICAL STUDY: The effect of naltrexone on amphetamine‐induced conditioned place preference and locomotor behaviour in the rat

Häggkvist, J., Lindholm, S., & Franck, J. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00150.x · Cited by 25 · see citing works

CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d-amphetamine: Role of mGlu5 receptors

Tzavara, E. T., Degroot, A., Wade, M. R., Davis, R. J., & Nomikos, G. G. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.11.003 · Cited by 25 · see citing works

Repeated amphetamine administration outside the home cage enhances drug-induced Fos expression in rat nucleus accumbens

Mattson, B. J., Crombag, H. S., Mitchell, T. B., SIMMONS, D., KREUTER, J., MORALES, M., & Hope, B. T. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.024 · Cited by 24 · see citing works

Different Black Box Warning Labeling for Same-Class Drugs

Panagiotou, O. A., Contopoulos‐Ioannidis, D. G., Papanikolaou, P. N., Ntzani, E., & Ioannidis, J. P. A. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1633-9 · Cited by 23 · see citing works

Upregulation of metabotropic glutamate receptor 8 mRNA expression in the rat forebrain after repeated amphetamine administration

Parelkar, N. K., & Wang, J. Q. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.01.015 · Cited by 23 · see citing works

The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum

Bosse, K. E., Jutkiewicz, E. M., Gnegy, M. E., & Traynor, J. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.017 · Cited by 22 · see citing works

Altered Acquisition and Extinction of Amphetamine-Paired Context Conditioning in Genetic Mouse Models of Altered NMDA Receptor Function

Benneyworth, M. A., & Coyle, J. T. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.108 · Cited by 22 · see citing works

Lsamp–/– mice display lower sensitivity to amphetamine and have elevated 5-HT turnover

Innos, J., Leidmaa, E., Philips, M., Sütt, S., O’Leary, A., Harro, J., Kõks, S., & Vasar, E. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.077 · Cited by 21 · see citing works

Acute Amphetamine Exposure Selectively Desensitizes κ-Opioid Receptors in the Nucleus Accumbens

Xia, Y., Li, H., Whistler, J. L., & Hjelmstad, G. O. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301463 · Cited by 21 · see citing works

Behavioral Neurobiology of Bipolar Disorder and its Treatment

Manji, H. K., & Zarate, C. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-15757-8 · Cited by 20 · see citing works

Chronic pentobarbital administration alters ?-aminobutyric acidA receptor ?6-subunit mRNA levels and diazepam-insensitive [3H]Ro15-4513 binding

Ito, T., Suzuki, T., Wellman, S. E., & Ho, I. K. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199602)22:2 · Cited by 18 · see citing works

Periadolescent amphetamine treatment causes transient cognitive disruptions and long‐term changes in hippocampal LTP depending on the endogenous expression of pleiotrophin

Gramage, E., Olmo, N. D., Fole, A., Martín, Y. B., & Herradón, G. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00362.x · Cited by 17 · see citing works

Regulation of group I metabotropic glutamate receptor expression in the rat striatum and prefrontal cortex in response to amphetamine in vivo

Shaffer, C., Guo, M.-L., Fibuch, E. E., Mao, L.-M., & Wang, J. Q. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.062 · Cited by 17 · see citing works

Age-related differences in amphetamine sensitization: Effects of prior drug or stress history on stimulant sensitization in juvenile and adult rats

Doremus‐Fitzwater, T. L., & SPEAR, L. P. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.05.005 · Cited by 16 · see citing works

The Role of BDNF/TrkB Signaling in Acute Amphetamine-Induced Locomotor Activity and Opioid Peptide Gene Expression in the Rat Dorsal Striatum

McGinty, J. F., Bache, A. J., Coleman, N. T., & Sun, W. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00060 · Cited by 16 · see citing works

Effect of amphetamine place conditioning on excitatory synaptic events in the basolateral amygdala ex vivo

Hetzel, A., Meredith, G. E., Rademacher, D. J., & Rosenkranz, J. A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.015 · Cited by 12 · see citing works

The Role of the Aminergic Systems in the Pathophysiology of Bipolar Disorder

Walderhaug, E., Varga, M., Pedro, M. S., Hu, J., & Neumeister, A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_72 · Cited by 12 · see citing works

Differential effects of intermittent and continuous exposure to novel environmental stimuli on the development of amphetamine-induced behavioral sensitization in mice: Implications for addiction

Fukushiro, D. F., Josino, F. S., Saito, L. P., Costa, J. M., Zanlorenci, L. H. F., Berro, L. F., Fernandes‐Santos, L., Morgado, F., Mári-Kawamoto, E., & Frussa‐Filho, R. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.12.026 · Cited by 12 · see citing works

Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice

El-Ghundi, M., Fan, T., Karasinska, J. M., Yeung, J. M., Zhou, M., O’Dowd, B. F., & George, S. R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1690-5 · Cited by 11 · see citing works

Amphetamine regulates NR2B expression in Go2α knockout mice and thereby sustains behavioral sensitization

Brunk, I., Sanchis‐Segura, C., Blex, C., Perreau‐Lenz, S., Bilbao, A., Spanagel, R., & Ahnert‐Hilger, G. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06921.x · Cited by 5 · see citing works

Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice

Managò, F., Lopez, S., Oliverio, A., Amalric, M., Mele, A., & Leonibus, E. D. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2925-4 · Cited by 4 · see citing works

Kinetics, mechanism, and inhibition of monoamine oxidase

Ramsay, R. R., & Albreht, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1861-9 · Cited by 108 · see citing works

Clinical management of negative symptoms of schizophrenia: An update

Tsapakis, E.-M., Dimopoulou, T., & Tarazi, F. I. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.008 · Cited by 72 · see citing works

Binge-eating disorder: Clinical and therapeutic advances

Hutson, P. H., Balodis, I. M., & Potenza, M. N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.002 · Cited by 59 · see citing works

Environmental and Pharmacological Modulation of Amphetamine- Induced 50-kHz Ultrasonic Vocalizations in Rats

Rippberger, H., van Gaalen, M. M., Schwarting, R. K. W., & Wöhr, M. (2015) · Current Neuropharmacology · doi:10.2174/1570159x1302150525124408 · Cited by 42 · see citing works

Effects of amphetamine on pro-social ultrasonic communication in juvenile rats: Implications for mania models

Engelhardt, K.-A., Fuchs, E., Schwarting, R. K. W., & Wöhr, M. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.01.003 · Cited by 40 · see citing works

Scopolamine and amphetamine produce similar decision-making deficits on a rat gambling task via independent pathways

Silveira, M. M., Malcolm, E., Shoaib, M., & Winstanley, C. A. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.029 · Cited by 31 · see citing works

Characterization of Amphetamine, Methylphenidate, Nicotine, and Atomoxetine on Measures of Attention, Impulsive Action, and Motivation in the Rat: Implications for Translational Research

Higgins, G. A., Silenieks, L. B., MacMillan, C., Thevarkunnel, S., Parachikova, A. I., Mombereau, C., Lindgren, H. S., & Bastlund, J. F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00427 · Cited by 25 · see citing works

Behavioral Battery for Testing Candidate Analgesics in Mice. I. Validation with Positive and Negative Controls

Diester, C. M., Santos, E. J., Moerke, M. J., & Negus, S. S. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000464 · Cited by 23 · see citing works

Memantine improves memory impairment and depressive-like behavior induced by amphetamine withdrawal in rats

Marszalek-Grabska, M., Gibula-Bruzda, E., Jenda, M., Gawel, K., & Kotlinska, J. H. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.026 · Cited by 22 · see citing works

The effects of amphetamine exposure on juvenile rats on the neuronal morphology of the limbic system at prepubertal, pubertal and postpubertal ages

Tendilla‐Beltrán, H., Arroyo‐García, L. E., Díaz, A., Camacho‐Abrego, I., de la Cruz, F., Moreno, A. R., & Flores, G. (2016) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2016.05.004 · Cited by 20 · see citing works

Chronic atomoxetine treatment during adolescence does not influence decision-making on a rodent gambling task, but does modulate amphetamine’s effect on impulsive action in adulthood

Silveira, M. M., Murch, W. S., Clark, L., & Winstanley, C. A. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000203 · Cited by 21 · see citing works

Mapping trait-like socio-affective phenotypes in rats through 50-kHz ultrasonic vocalizations

Engelhardt, K.-A., Schwarting, R. K. W., & Wöhr, M. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4746-y · Cited by 18 · see citing works

Differential effects of dopamine receptor subtype-specific agonists with respect to operant behavior maintained on a differential reinforcement of low-rate responding (DRL) schedule

Chiang, F.-K., Cheng, R., & Liao, R. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.01.002 · Cited by 15 · see citing works

Astrotactin 2 ( ASTN2 ) regulates emotional and cognitive functions by affecting neuronal morphogenesis and monoaminergic systems

Ito, T., Yoshida, M., Aida, T., Kushima, I., Hiramatsu, Y., Ono, M., Yoshimi, A., Tanaka, K., Ozaki, N., & Noda, Y. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15790 · Cited by 13 · see citing works

The effects of amphetamine on working memory and locomotor activity in adult rats administered risperidone early in life

Bardgett, M. E., Crane, C., Thompson, E. C. B., Cox, B., & Downnen, T. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.044 · Cited by 13 · see citing works

Modafinil reduces amphetamine preference and prevents anxiety-like symptoms during drug withdrawal in young rats: Involvement of dopaminergic targets in VTA and striatum

Dias, V. T., Rosa, H. Z., D’avila, L. F., Vey, L. T., Barcelos, R. C. S., & Bürger, M. E. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.007 · Cited by 13 · see citing works

Systematic reviews of the acute effects of amphetamine on working memory and other cognitive performances in healthy individuals, with a focus on the potential influence of personality traits

Kassim, F. M. (2023) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2856 · Cited by 11 · see citing works

Reduced Efficacy of d-Amphetamine and 3,4-Methylenedioxymethamphetamine in Inducing Hyperactivity in Mice Lacking the Postsynaptic Scaffolding Protein SHANK1

Sungur, A. Ö., Redecker, T. M., Andres, E., Dürichen, W., Schwarting, R. K. W., del Rey, A., & Wöhr, M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00419 · Cited by 8 · see citing works

Pharmacological Strategies to Improve Mental Performance

Cutsem, J. V., & Pattyn, N. (2024) · Routledge eBooks · doi:10.4324/9781003378969-8 · Cited by 4 · see citing works

The Effects of Drug Treatments for ADHD in Measures of Cognitive Performance

Higgins, G. A., & Silenieks, L. B. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_341 · Cited by 4 · see citing works

Dexamphetamine influences funneling illusion based on psychometric score

Kassim, F. M., Lim, J. H. M., Albrecht, M. A., & Martin-Iverson, M. T. (2023) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2862 · Cited by 4 · see citing works

Dexamphetamine widens temporal and spatial binding windows in healthy participants

Kassim, F. M., Krakonja, S., Keay, E. A., Iyyalol, R., Rodger, J., Albrecht, M. A., & Martin-Iverson, M. T. (2023) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.220149 · Cited by 2 · see citing works

Polysubstance Use and Overdose Visualized via Maps: Amphetamines and Cocaine

Raffa, R. B., Pergolizzi, J. V., & Cukier, H. (2022) · Pharmacology &amp Pharmacy · doi:10.4236/pp.2022.135011

Aplicação da análise multivariada para o mapeamento dos casos de intoxicações agudas atendidos no Centro de Controle de Intoxicações da cidade de São Paulo

Eller, S. C. W. D. S. (2018) · doi:10.11606/t.9.2018.tde-11062018-102753 · Cited by 1 · see citing works

Effects of Early Adolescent Exposure to d -Amphetamine in a Rodent Model of Nicotine Reward

Harvey, E. L. (2017)

Development of a Semimechanistic Pharmacokinetic-Pharmacodynamic Model Describing Dextroamphetamine Exposure and Striatal Dopamine Response in Rats and Nonhuman Primates following a Single Dose of Dextroamphetamine

van Gaalen, M. M., Schlumbohm, C., Folgering, J. H. A., Adhikari, S., Bhattacharya, C. S., Steinbach, D., & Stratford, R. E. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.254508

Desenvolvimento e aplicação de método analítico para determinação de substâncias psicoativas em amostras biológicas de motociclistas empregando LC-MS/MS

Cypriano, K. D. M. (2019) · doi:10.11606/t.9.2019.tde-17122019-192234

Neurochemical, neurobiological and toxic effects of Amphetamine on memory consolidation. Review

Tóth, M. (2019)

Chapter 45. Psychostimulants and Wakefulness-Promoting Agents

DeBattista, C. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as45

Pooled analysis assessing the efficacy and safety of amphetamine derivative adjunctive therapy for bipolar depression

Frye, M. A., Sánchez-Ruiz, J. A., Ali, D. N., Núñez, N. A., Lindstrom, K., Pazdernik, V. K., Mori, N. N., Singh, B., Barboza, A. B. C., Georgiev, G., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122257

Neuroethological assessment of amphetamine-induced behavioral changes and their reversal by neuroleptics: Focus on the amygdala and nucleus accumbens

Wang, Z., & Rebec, G. V. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(98)00046-3 · Cited by 4 · see citing works

Cocaine and amphetamine-like psychostimulants: neurocircuitry and glutamate neuroplasticity

Kalivas, P. W. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.4/pkalivas · Cited by 117 · see citing works

Amphetamine and the Biology of Neuronal Morphology

Tendilla‐Beltrán, H., Arroyo‐García, L. E., & Flores, G. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_115 · Cited by 1 · see citing works

Neuropsychopharmacology and the Affective Disorders

Schildkraut, J. J. (1969) · New England Journal of Medicine · doi:10.1056/nejm196908072810606 · Cited by 105 · see citing works

Rapid Synaptic Plasticity of Glutamatergic Synapses on Dopamine Neurons in the Ventral Tegmental Area in Response to Acute Amphetamine Injection

Faleiro, L. J., Jones, S., & Kauer, J. A. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300495 · Cited by 76 · see citing works